Array Technologies, Inc. Solar, 967.77M. ARTL, Artelo Biosciences, Inc ArriVent BioPharma, Inc. Biotechnology, 760.38M. AVD, American Vanguard Corporation
News about Array BioPharma Inc, including commentary and archival articles published in The New York Times.
BOULDER, Colo, J /PRNewswire/ - Array BioPharma Inc. ( Array ) today announced that, in connection with the closing of the merger (the Merger ) contemplated by the Agreement and
On Octo, the Food and Drug Administration approved encorafenib (Braftovi, Array BioPharma Inc, a wholly owned subsidiary of Pfizer) with
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs
Distributed by: Array BioPharma Inc, a wholly owned subsidiary of Pfizer Inc. Boulder, Colorado . BRAFTOVI
Tony Piscopio describes the year that Boulder-based Array BioPharma Inc. was acquired by Pfizer Inc. (NYSE: PFE) as transformative for the
Boulder s Array BioPharma Inc. is merging with Pfizer Inc. in an $11.4 billion deal. The merger agreement was announced Monday. Array BioPharma is a commercial stage biopharmaceutical company
View Array BioPharma Inc. ( location in Colorado, United States, revenue, competitors and contact information.
Comments